"Caveolin 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A tyrosine phosphoprotein that plays an essential role in CAVEOLAE formation. It binds CHOLESTEROL and is involved in LIPIDS transport, membrane traffic, and SIGNAL TRANSDUCTION.
| Descriptor ID |
D051242
|
| MeSH Number(s) |
D12.644.360.024.264 D12.776.157.057.010 D12.776.476.024.280 D12.776.543.990.100.500 D12.776.744.287
|
| Concept/Terms |
Caveolin 1- Caveolin 1
- Vesicular Integral Membrane Protein 21 kDa
- Caveolin-1
- VIP21 Protein
|
Below are MeSH descriptors whose meaning is more general than "Caveolin 1".
Below are MeSH descriptors whose meaning is more specific than "Caveolin 1".
This graph shows the total number of publications written about "Caveolin 1" by people in this website by year, and whether "Caveolin 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 3 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 2 | 4 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2020 | 2 | 1 | 3 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Caveolin 1" by people in Profiles.
-
Inhibition of glycolysis and Src/Akt signaling reduces Caveolin-1-enhanced metastasis. Biomed Pharmacother. 2024 Jul; 176:116841.
-
Targeted Genome Sequencing Identifies Multiple Rare Variants in?Caveolin-1 Associated with Obstructive Sleep Apnea. Am J Respir Crit Care Med. 2022 11 15; 206(10):1271-1280.
-
DCBLD2 regulates vascular hyperplasia by modulating the platelet derived growth factor receptor-? endocytosis through Caveolin-1 in vascular smooth muscle cells. FASEB J. 2022 09; 36(9):e22488.
-
Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer. JCI Insight. 2021 10 22; 6(20).
-
Dasatinib, paclitaxel, and carboplatin in women with advanced-stage or recurrent endometrial cancer: A pilot clinical and translational study. Gynecol Oncol. 2021 04; 161(1):104-112.
-
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer. Nat Commun. 2020 08 27; 11(1):4279.
-
Anti-fibrotic effects of different sources of MSC in bleomycin-induced lung fibrosis in C57BL6 male mice. Respirology. 2021 02; 26(2):161-170.
-
Interplay Between Statins, Cav1 (Caveolin-1), and Aldosterone. Hypertension. 2020 09; 76(3):962-967.
-
Caveolin and lipid domains-close companions in managing cellular pathways. Cancer Metastasis Rev. 2020 06; 39(2):341-342.
-
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBioMedicine. 2018 Dec; 38:100-112.